Arixtra treats and prevents blood clots. Tell your doctor right away if you notice signs of excessive bleeding.
Arixtra is a prescription medication used to treat and prevent blood clots. Arixtra, a "blood thinner", belongs to a group of drugs called factor Xa (ten A) inhibitor anticoagulants. These medications work by decreasing the ability of blood to form clots.
Arixtra comes in an injectable form and is given by injection under the skin once daily.
How was your experience with Arixtra?
Arixtra Cautionary Labels
Uses of Arixtra
Arixtra is a prescription medicine that “thins your blood” (also known as an anticoagulant). Arixtra is used to:
- help prevent blood clots from forming in patients who have had certain surgeries of the hip, knee, or the stomach area (abdominal surgery)
- treat people who have blood clots in their legs or blood clots that travel to their lungs
This medication may be prescribed for other uses. Ask your doctor or pharmacist for more information.
For more information on this medication choose from the list of selections below.
Arixtra Drug Class
Arixtra is part of the drug class:
Side Effects of Arixtra
Arixtra can cause serious side effects. See “Drug Precautions”.
- Severe bleeding. Certain conditions can increase your risk for severe bleeding, including:
- some bleeding problems
- some gastrointestinal problems including ulcers
- some types of strokes
- uncontrolled high blood pressure
- diabetic eye disease
- spinal surgery
- Certain kidney problems can also increase your risk of bleeding with Arixtra. Your doctor may check your kidney function while you are taking Arixtra.
- People undergoing surgery who weigh less than 110 pounds should not use Arixtra.
- Low blood platelets. Low blood platelets can happen when you take Arixtra. Platelets are blood cells that help your blood to clot normally. Your doctor may check your platelet counts while you take Arixtra. You may bruise or bleed more easily while taking Arixtra, and it may take longer than usual for bleeding to stop.
- Tell your doctor if you have any of these signs or symptoms of bleeding while taking Arixtra:
- any bleeding
- rash of dark red spots under the skin
- Allergic reactions. If you experience swelling of the face or mouth or have difficulty in swallowing or breathing, contact your doctor right away. You should stop Arixtra if this happens.
Other side effects include:
- Injection site reactions. Bleeding, rash, and itching can happen at the place where you inject Arixtra.
- Low red blood cell counts (anemia). Your doctor may check your red blood cell counts while you are taking Arixtra.
- Increased liver enzyme test results. Your doctor may check your liver function while you are taking Arixtra.
- Sleep problems (insomnia).
These are not all the possible side effects of Arixtra. Call your doctor if you have any side effects that bother you or don’t go away.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Tell your doctor about all the medicines you take including prescriptions and non-prescription medicines, vitamins, and herbal supplements. Some medicines can increase your risk of bleeding. Especially tell your doctor if you take:
- NSAIDS (such as ibuprofen or naproxen)
- other blood thinner medicines, such as clopidogrel or warfarin
This is not a complete list of Arixtra drug interactions. Ask your doctor or pharmacist for more information.
Certain medical procedures involving the spine, such as an epidural (pain medication given through the spine), spinal anesthesia, or spinal puncture, may be used during your hospital stay. If you need any of these procedures while receiving Arixtra, heparins, heparinoids, or low-molecular weight heparins (anticoagulants), you may be at risk for having a blood clot (hematoma) in or around your spine. This type of clot is very serious, as it can cause long-term and possibly permanent paralysis (loss of the ability to move).
If you receive Arixtra after an epidural or spinal anesthetic is used, as the anesthesia for your surgery, your doctor will watch you closely for problems with feeling (sensation) and being able to move. Tell your doctor right away if you have any of these signs and symptoms, especially in your legs and feet:
- muscle weakness
Because the risk of bleeding may be higher, tell your doctor before taking Arixtra if you:
- are also taking certain other medicines that affect blood clotting such as aspirin, an NSAID (for example, ibuprofen or naproxen), clopidogrel, or warfarin sodium
- have bleeding problems
- had problems in the past with pain medication given through the spine
- have had surgery to your spine
- have a spinal deformity
Do not take Arixtra if you have:
- certain kidney problems
- active bleeding problems
- an infection of the heart
- low platelet counts and if you test positive for a certain antibody while you are taking Arixtra
- have a history of a serious hypersensitivity/allergic reaction to Arixtra or to any of its ingredients
People who weigh less than 110 pounds (50 kg) should not use Arixtra to prevent blood clots from forming after surgery.
Tell your doctor about all of your medical conditions, including if you:
- have had any bleeding problems (such as stomach ulcers)
- have had a stroke
- have had recent surgeries, including eye surgery
- have diabetic eye disease
- have kidney problems
- have uncontrolled high blood pressure
- have a latex allergy
- are pregnant or breastfeeding
Tell your doctor about all the medicines you take including prescriptions and non-prescription medicines, vitamins, and herbal supplements.
Arixtra and Pregnancy
Tell your doctor if you are pregnant or plan to become pregnant.
The FDA categorizes medications based on safety for use during pregnancy. Five categories - A, B, C, D, and X, are used to classify the possible risks to an unborn baby when a medication is taken during pregnancy.
Arixtra falls into category B. There are no well-done studies that have been done in humans with Arixtra. But in animal studies, pregnant animals were given this medication, and the babies did not show any medical issues related to this medication.
Arixtra and Lactation
It is not known if Arixtra crosses into human milk. Because many medications can cross into human milk and because of the possibility for serious adverse reactions in nursing infants with use of this medication, a choice should be made whether to stop nursing or stop the use of this medication. Your doctor and you will decide if the benefits outweigh the risk of using Arixtra.
- Take Arixtra exactly as prescribed by your doctor.
- Arixtra is given by injection under the skin (subcutaneous injection).
- If your doctor tells you that you may give yourself injections of Arixtra at home, you will be shown how to give the injections first before you do them on your own.
- Tell your doctor if you have any bleeding or bruising while taking Arixtra.
- If you miss a dose of Arixtra, take your dose as soon as you remember. Do not take 2 doses at the same time.
- If you take too much Arixtra, call your doctor right away.
- Do not use Arixtra if:
- the solution appears discolored (the solution should normally appear clear),
- you see any particles in the solution, or
- the syringe is damaged.
How to give an injection of Arixtra:
Arixtra is injected into a skin fold of the lower stomach area (abdomen). Do not inject Arixtra into muscle. Usually a doctor or nurse will give this injection to you. In some cases you may be taught how to do this yourself. Be sure that you read, understand, and follow the step-by-step instructions in this leaflet, on how to give yourself an injection of Arixtra.
1. Wash your hands thoroughly with soap and water. Towel dry.
2. Sit or lie down in a comfortable position. Choose a spot on the lower stomach area (abdomen), at least 2 inches below your belly button. Change (alternate) between using the left and right side of the lower abdomen for each injection. If you have any questions talk to your nurse or doctor.
3. Clean the injection area with an alcohol swab.
4. Remove the needle guard, by first twisting it and then pulling it in a straight line away from the body of the syringe. Discard the needle guard. To prevent infection, do not touch the needle or let it come in contact with any surface before the injection. A small air bubble in the syringe is normal. To be sure that you do not lose any medicine from the syringe, do not try to remove air bubbles from the syringe before giving the injection.
5. Gently pinch the skin that has been cleaned to make a fold. Hold the fold between the thumb and the forefinger of one hand during the entire injection.
6. Hold the syringe firmly in your other hand using the finger grip. Insert the full length of the needle directly up and down (at an angle of 90°) into the skin fold.
7. Inject all of the medicine in the syringe by pressing down on the plunger as far as it goes. This will activate the automatic needle protection system.
8. Release the plunger. The needle will withdraw automatically from the skin, and pull back (retract) into the security sleeve where it will be locked.
Follow the instructions given to you by your nurse or doctor about the right way to throw away used syringes and needles. There may be state laws about the right way to dispose of used syringes, needles, and disposal containers.
The recommended daily Arixtra dose ranges from 2.5 mg to 10 mg. Your doctor will determine the best dosage for you based on the medical condition being treated as well as several other factors.
If you take too much Arixtra, call your doctor or local Poison Control Center right away.
- Store Arixtra at room temperature 59°F to 86°F (15°C to 30°C). Do not freeze.
- Safely, throw away Arixtra that is out of date or no longer needed.
- Keep Arixtra and all medicines out of the reach of children.
Arixtra FDA Warning
WARNING: SPINAL/EPIDURAL HEMATOMAS
Epidural or spinal hematomas may occur in patients who are anticoagulated with low molecular weight heparins (LMWH), heparinoids, or Arixtra and are receiving neuraxial anesthesia or undergoing spinal puncture. These hematomas may result in long-term or permanent paralysis. Consider these risks when scheduling patients for spinal procedures. Factors that can increase the risk of developing epidural or spinal hematomas in these patients include:
- use of indwelling epidural catheters
- concomitant use of other drugs that affect hemostasis, such as non-steroidal anti-inflammatory drugs (NSAIDs), platelet inhibitors, or other anticoagulants
- a history of traumatic or repeated epidural or spinal puncture
- a history of spinal deformity or spinal surgery
Monitor patients frequently for signs and symptoms of neurologic impairment. If neurologic compromise is noted, urgent treatment is necessary.
Consider the benefit and risks before neuraxial intervention in patients anticoagulated or to be anticoagulated for thromboprophylaxis.